Guilty plea expected from former Insys CEO — 5 details

Former Insys Therapeutics CEO Michael Babich is expected to plead guilty in an opioid kickbacks case, Reuters Health News reports.

What you should know:

1. Mr. Babich allegedly participated in a conspiracy to bribe doctors in exchange for prescribing Subsys, a pain management spray that contains fentanyl, from 2012 to 2015. He resigned as Insys' CEO in 2015.

2. Mr. Babich is expected to plead guilty to conspiracy and mail fraud charges in federal court. The terms of his anticipated plea deal haven't been disclosed.

3. Insys' former Vice President of Sales Alec Burlakoff pleaded guilty in November 2018 and agreed to testify on behalf of the government. Natalie Babich, a former Insys sales representative and Mr. Babich's wife, also pleaded guilty to conspiracy in 2017 and became a government witness.

4. Five former Insys leaders are scheduled to appear in court for their roles in the alleged scheme in the coming weeks. Among them is Insys Founder and former Chairman John Kapoor, who pleaded not guilty to racketeering conspiracy.

5. Insys agreed to settle a related federal government probe for at least $150 million in 2018, and the company is under new management.

More articles on anesthesia:
Anesthesia provider hires former Pinnacle Partners in Medicine CEO — 3 insights
Anesthesiologists rank No. 1 in salary — Here's how other jobs pay
Texas Society of Anesthesiologists honors Dr. H.A. Tillmann Hein — 5 highlights

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers